SMSPHARMA Quarterly Results, Profit & Loss, Balance Sheet (SMSPHARMA)

SMSPHARMA quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • SMSPHARMA Financials
  • SMSPHARMA Shareholding Pattern
  • SMSPHARMA Earnings Documents
  • SMSPHARMA Announcements
  • SMSPHARMA Corporate Actions
  • SMSPHARMA Bulk, Block & Insider Deals
  • SMSPHARMA Delivery Data
  • SMSPHARMA Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

SMS Pharmaceuticals Ltd (SMSPHARMA) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

SMS Pharmaceuticals Ltd reported sales of ₹316 Cr, operating profit of ₹68 Cr (OPM 21%) and net profit of ₹40 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

SMSPHARMA quarterly results (₹ Cr)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales173248196242210238207316
YoY Sales growth71192321-4630
Expenses140207157194167198166248
Operating Profit3341394844404168
OPM19%16%20%20%21%17%20%21%
Other Income21114321
Interest45666566
Depreciation99101010101010
Profit before tax2229243431272753
Tax24%30%23%26%26%23%26%25%
Net Profit1820202523332140
EPS in Rs2.152.292.312.72.513.492.234.26
SMSPHARMA profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales520522709783887971
Sales growth-8036101313
Expenses405467593644715779
Operating Profit11555117139172192
OPM22%10%16%18%19%20%
Other Income554689
Interest192224192323
Depreciation323232344041
Profit before tax6856692117138
Tax1%28%26%27%25%-
Net Profit62-75069102117
EPS in Rs7.35-0.835.887.810.8912.49
Dividend Payout4%-36%7%5%4%-
SMSPHARMA balance sheet (₹ Cr)
MetricMar 2024Mar 2025Sep 2025Mar 2026Sep 2026
Equity Capital89999
Reserves528631720776833
Borrowings281311324365349
Other Liabilities217202223212268
Total Liabilities1,0341,1531,2761,3621,461
Fixed Assets437533517534582
CWIP303554122138
Investments1112142628
Other Assets556573692681712
Total Assets1,0341,1531,2761,3621,461
SMSPHARMA cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity4522508259
Cash from Investing Activity-27-30-52-123-131
Cash from Financing Activity-12-32314776
Net Cash Flow6-392954
Free Cash Flow18-7-2-42-71
CFO/OP52%50%56%73%49%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit5250567349
SMSPHARMA ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days341041229589
Inventory Days333243201241260
Days Payable971171309689
Cash Conversion Cycle270230192239260
Working Capital Days94104858898
ROCE13%4%12%13%13%
  • SMSPHARMA Shareholding Pattern
  • SMSPHARMA Earnings Concalls
  • SMSPHARMA Growth Catalysts
  • SMSPHARMA Corporate Actions
  • SMSPHARMA Announcements
  • SMSPHARMA Results & Documents
  • SMSPHARMA Bulk & Block Deals
  • SMSPHARMA Delivery Data